CRYSTAL JONES: Open Payments
NPI 1275914285 · NORTH WILKESBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,336 in 71 payments from 22 companies in 2025. Trend: 2023 $1,271 · 2024 $1,369 · 2025 $1,336
Food & beverage: $1,336
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $267 |
| Novo Nordisk Inc | 10 | $154 |
| Axsome Therapeutics, Inc. | 5 | $109 |
| GlaxoSmithKline, LLC. | 5 | $106 |
| Otsuka America Pharmaceutical, Inc. | 5 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| PFIZER INC. | 3 | $51 |
| ABBVIE INC. | 2 | $45 |
| Viatris Specialty LLC | 2 | $43 |
Products named: REXULTI, Auvelity, BREZTRI, TRELEGY ELLIPTA, AIRSUPRA, Wegovy, TRINTELLIX, FARXIGA.
Industry payments across NC — which companies pay providers there.
